View in EDS HTML Full Text PDF Full Text

Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild‐moderate fibrosis: Results from a real‐world cohort.

Saved in:
Bibliographic Details
Title: Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild‐moderate fibrosis: Results from a real‐world cohort.
Authors: Puigvehí, Marc1, De Cuenca, Beatriz2, Viu, Ana1, Diago, Moisés3, Turnes, Juan4, Gea, Francisco5, Pascasio, Juan M.6, Lens, Sabela7, Cabezas, Joaquín8, Badia, Ester9, Olveira, Antonio10, Morillas, Rosa M.11, Torras, Xavier12, Montoliu, Silvia13, Cordero, Patricia14, Castro, José L.15, Salmerón, Javier16, Molina, Esther17, Sánchez‐Ruano, Juan J.18, Moreno, Javier19
Source: Liver International. Jan2019, Vol. 39 Issue 1, p90-97. 8p. 3 Charts, 3 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14783223
DOI:10.1111/liv.13950